Charles River Laboratories | CRL - Assets



Charles River Laboratories reported $7.56B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Agilent USD 12.23B 68M Jul/2025
Align Technology USD 6.22B 116.27M Jun/2025
Bio-Rad Laboratories USD 10.21B 687.2M Jun/2025
Bruker USD 6.34B 406.7M Jun/2025
Cardinal Health USD 53.12B 3.25B Jun/2025
Charles River Laboratories USD 7.56B 21.82M Jun/2025
Cigna USD 151.65B 993M Jun/2025
CVS Health USD 258.34B 2.76B Jun/2025
Danaher USD 81.62B 2.5B Jun/2025
Dentsply International USD 6.07B 19M Jun/2025
Elevance Health USD 121.94B 2.22B Jun/2025
Galapagos EUR 3.82B 203.72M Jun/2025
Hologic USD 8.81B 261M Jun/2025
Humana USD 50.36B 573M Jun/2025
Illumina USD 6.09B 95M Jun/2025
Incyte USD 5.82B 71.99M Jun/2025
IQVIA Holdings USD 28.63B 1.31B Jun/2025
Laboratory Of America USD 18.06B 456.1M Jun/2025
Lonza CHF 19.73B 1.85B Dec/2024
McKesson USD 81.31B 6.17B Jun/2025
Merck EUR 47.35B 2.02B Jun/2025
Mettler Toledo International USD 3.4B 165.79M Jun/2025
Novartis USD 104.4B 4.45B Jun/2025
Pfizer USD 206.1B 1.93B Jun/2025
Quest Diagnostics USD 15.97B 172M Jun/2025
Revvity USD 12.36B 2.06M Jun/2025
Thermo Fisher Scientific USD 101.23B 2.19B Jun/2025
United Therapeutics USD 7.91B 164.1M Jun/2025
UnitedHealth USD 308.57B 1.22B Jun/2025
Waters USD 4.72B 126.5M Jun/2025
West Pharmaceutical Services USD 3.95B 334.6M Jun/2025